logo
Select company
Select metric
$ -7.08MConsolidated Income
VS
Market
38
Sector
72
Industry
85
History
98
$ 2.2Close
$ 1.01 - $ 6.6 52-Week Range
Ticker Information

Ticker

PHIO

Company Name

PHIO PHARMACEUTICALS CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHIO PHARMACEUTICALS CORP - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PHIO - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -7.08M
3/31/2025$ -6.76M
12/31/2024$ -7.15M
9/30/2024$ -7.42M
6/30/2024$ -8.68M
3/31/2024$ -9.38M
12/31/2023$ -10.83M
9/30/2023$ -11.66M
6/30/2023$ -12.46M
3/31/2023$ -12.44M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHIO PHARMACEUTICALS CORP's latest trailing twelve months (TTM) Cons. Inc. stands at $ -8.99M.
  • Over the past 5 years, PHIO PHARMACEUTICALS CORP's average Cons. Inc. has been $ -10.33M.
  • The median Cons. Inc. for PHIO PHARMACEUTICALS CORP during this period was $ -10.85M
  • PHIO PHARMACEUTICALS CORP reached its highest Cons. Inc. over the past 5 years at $ -6.76M.
  • The lowest Cons. Inc. recorded by PHIO PHARMACEUTICALS CORP in the same timeframe $ -13.29M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

PHIO - Consolidated Income, Last 5 years

$ -13.29M

Minimum

Dec 31, 2021

$ -6.76M

Maximum

Mar 31, 2025

$ -10.33M

Average

$ -10.85M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M